Could a mouth injection cure dry mouth? new trial begins

NCT ID NCT07309588

First seen Jan 05, 2026 · Last updated Jun 23, 2026 · Updated 36 times

Summary

This study tests whether injections of a solution containing hyaluronic acid and amino acids (Sunecos-200) can relieve dry mouth in adults with hyposalivation. 100 participants will receive either the injections or no treatment every two weeks for four sessions. Researchers will measure pain, saliva flow, and symptom improvement using questionnaires.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for XEROSTOMIA DUE TO HYPOSECRETION OF SALIVARY GLAND are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Department of Periodontology and Oral Mucosa Diseases, Poznan University of Medical Sciences

    Poznan, Greater Poland Voivodeship, 60-812, Poland

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Sunecos-200 (non-crosslinked hyaluronic acid and amino acids solution)

What this could lead to

If it works, this could offer a new way to relieve chronic dry mouth and improve comfort for people with hyposalivation.

What could go wrong

This is an early-phase trial with only 100 participants, so results may not apply to everyone. The treatment involves injections into the mouth, which may cause pain or side effects.

Conditions

The condition(s) this trial relates to.

Xerostomia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.